Evidence map›Paper›PMID 28889067›Full record

ReviewCurrent opinion in immunology2017

Immune monitoring for precision medicine in allergy and asthma.

Scott Dexter Boyd, Ramona Amy Hoh, Kari Christine Nadeau, Stephen Joseph Galli

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Severe T2-high asthma in the biologics era: European experts' opinion.European respiratory review : an official journal of the European Respiratory Society · 2019
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Scott Dexter BoydDepartments of Pathology, Stanford, CA 94305, USA; Departments of the Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA 94305, USA.
Ramona Amy HohDepartments of Pathology, Stanford, CA 94305, USA; Departments of the Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA 94305, USA.
Kari Christine NadeauDepartments of Medicine, Stanford, CA 94305, USA; Departments of Pediatrics, Stanford, CA 94305, USA; Departments of the Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA 94305, USA.
Stephen Joseph GalliDepartments of Pathology, Stanford, CA 94305, USA; Departments of Microbiology & Immunology, Stanford, CA 94305, USA; Departments of the Sean N. Parker Center for Allergy and Asthma Research, Stanford, CA 94305, USA; Departments of the Stanford Center for Genomics and Personalized Medicine, Stanford, CA 94305, USA. Electronic address: sgalli@stanford.edu.
Stanford Medicine · US

Funding

Tracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI CHINTHRAJAH, R. SHARON · 2013 to 2025
$17.3M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIESR01AI125567 · NIAID · STANFORD UNIVERSITY · PI BOYD, SCOTT DEXTER · 2017 to 2022
$2.6M
RabGEF1 in MyD88 signaling, skin immunity, and atopic dermatitisR01AR067145 · NIAMS · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2015 to 2019
$1.9M
NIAID NIH HHS R01 AI125567NIAID NIH HHS U01 AI147462NIAID NIH HHS U19 AI104209NIAMS NIH HHS R01 AR067145
6 · The paper itself

Abstract

'Precision Medicine' embodies the analyses of extensive data collected from patients and their environments to identify and apply patient-specific prophylactic strategies and medical treatments to improve clinical outcomes and healthcare cost-effectiveness. Many new methods have been developed for evaluating the activity of the human immune system. Such 'immune monitoring' approaches are now being used in studies of allergy and asthma in the hope of identifying better correlates of disease status, predictors of therapeutic outcomes, and potential side-effects of treatment. Together with analyses of family histories, genetic and other biometric data, and measurements of exposures to environmental and other risk factors for developing or exacerbating disease, immune monitoring approaches promise to enable 'Precision Medicine' for allergic diseases and asthma.

Indexed as

Precision MedicineAnti-Allergic AgentsAsthmaBiomarkers, PharmacologicalGene-Environment InteractionHumansHypersensitivityMonitoring, ImmunologicMonitoring, PhysiologicPedigreePrognosisRiskAnti-Allergic AgentsBiomarkers, Pharmacological

Identifiers

PMID28889067
PMCPMC5743231
OpenAlexW2752928520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.